Source:http://linkedlifedata.com/resource/umls/id/C0017631
MSH: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.,NCI: A short-acting, relatively high-potency, second-generation sulfonylurea compound with hypoglycemic activity. Gliclazide also increases peripheral insulin sensitivity. This agent is metabolized by CYP2C9.